Skip to main navigation

Back

Contact Revance
Login

Menu

Aesthetics
Back Aesthetics
Visit Site
Therapeutics
Back Therapeutics
Investors
Back Investors
LATEST NEWS
In the News

April 27, 2021

Experts Call These the Most Cutting-Edge Aesthetic Treatments

InStyle

All News
Company
Back Company
OUR LATEST
In the News

April 27, 2021

Experts Call These the Most Cutting-Edge Aesthetic Treatments

InStyle

Our Latest
News
Careers
Back Careers

facebook
instagram
twitter
linkedin

1222 Demonbreun St
20th Floor
Nashville, TN 37203

Contact Revance
Login

© Copyright 2022

All Rights Reserved

Breadcrumb

Home
Investors
Press releases

Press Releases

Press Releases

Items Per Page

Year

September 16, 2021

Revance to Showcase Data from Phase 3 ASPEN-1 Clinical Trial Evaluating Efficacy, Duration of Effect and Safety of DaxibotulinumtoxinA for Injection for Cervical Dystonia at International Parkinson and Movement Disorder Society Virtual Congress 2021

September 10, 2021

Revance Presents Data on the RHA® Collection of Dermal Fillers at the 2021 Virtual Skin of Color Update Meeting

September 2, 2021

Revance to Participate in the Wells Fargo Securities Healthcare Conference

September 1, 2021

Revance Announces Publication of Results on Static Glabellar Lines With Repeated Treatment of DaxibotulinumtoxinA for Injection From the SAKURA Clinical Program in Dermatologic Surgery

August 5, 2021

Revance Reports Second Quarter 2021 Financial Results, Provides Corporate Update

July 29, 2021

Revance to Release Second Quarter 2021 Financial Results on Thursday, August 5, 2021

May 26, 2021

Revance to Participate in Upcoming Virtual Healthcare Conferences

May 26, 2021

Revance Provides Update on DaxibotulinumtoxinA for Injection Pre-Approval Inspection

May 10, 2021

Revance Reports First Quarter 2021 Financial Results, Provides Corporate Update

May 3, 2021

Revance to Release First Quarter 2021 Financial Results on Monday, May 10, 2021

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Displaying 11 - 20 of 268

Investor Relations

Investor Relations
Press Releases
Events & Presentations
- Events
- Presentations and Corporate Materials
Corporate Governance
Financials & Filings
Stock Information
Analyst Coverage
Investor FAQs
Contact Us

image description

Revance - Shareholder Tools

Print Page
Printed Materials
Email Alerts
Download Library
RSS News Feeds
Share
Search

Keep up with Revance

Subscribe

1222 Demonbreun St
20th Floor
Nashville, TN 37203

facebook
instagram
twitter
linkedin

Aesthetics

Overview
RHA®
OPUL
Neuromodulator
Neuromodulator Uses
Clinical Highlights

Therapeutics

Overview
Cervical Dystonia
Upper Limb Spasticity
Plantar Fasciitis
Clinical Highlights

Investors

Investor Relations
Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
Analyst Coverage
Investor FAQ
Contact Us

Company

Overview
About Revance
Leadership Team
Board of Directors
Partnerships
Investigator Sponsored Trials
Medical Education Grants
Sustainability
Contact Revance

News

All News
In the News
Our Latest

Careers

Overview
Career Opportunities
Culture
Benefits & Perks
Privacy Notice

© Copyright 2022
All Rights Reserved
Terms of Use
Privacy Policy
Corporate Social Media Community Guidelines

Facebook
LinkedIn